The U.S. Food and Drug Administration (FDA) has given the green light to a revolutionary treatment for sickle cell disease, a painful blood disorder affecting around 100,000 individuals in the United States, primarily from Black or Latino communities. The breakthrough therapy, named Casgevy, is the world’s first-ever CRISPR-based gene-editing treatment. On December 8, 2023, the…
Read MoreIn a groundbreaking development, scientists at Verve Therapeutics, a Boston-based biotechnology company, have unveiled promising results from an experimental drug trial aimed at treating a severe genetic disorder linked to high levels of “bad cholesterol.” The research, known as the heart-1 clinical trial, focuses on a new genetic medicine called VERVE-101, offering a potential one-time…
Read MoreIn a groundbreaking investigation carried out by a collaborative team from Genomics England, the National Health Service (NHS) England, Queen Mary University of London, the University of Westminster, and Guy’s and St Thomas’ NHS Foundation Trust, researchers have unveiled the potential of significantly enhancing cancer treatment by merging whole-genome sequencing with clinical data. The study…
Read MoreIn the fascinating world of gene editing, a group of engineers at Duke University has just unveiled a groundbreaking technique that could revolutionize the way we treat diseases at their roots. This news stems from research released on October 4, 2023, in the esteemed journal Nature Communications. Collaborating with experts from Harvard University, MIT, University…
Read MoreIn a world where science fiction often captivates our imaginations, the real-life drama happening inside our cells can be just as intriguing. Billions of years ago, our ancestors struck a deal with protobacteria, inviting them into their cells. This ancient partnership led to the creation of mitochondria, cellular powerhouses essential for our survival. Today, scientists…
Read MoreIn a pivotal study unveiled on December 5, 2023, a collaboration of scientists from Vanderbilt University, the University of Michigan at Ann Arbor, and various research institutions have successfully demystified the intricate genetic pathways contributing to the onset of Type 2 Diabetes (T2D). This groundbreaking investigation yields crucial insights into the early phases of the…
Read MoreIn a groundbreaking development, the world’s largest collection of full human genomes has been made available to scientists. On December 2, 2023, the UK Biobank, a repository of health, genomic, and biological data, released the complete genome sequences of 500,000 British volunteers. This monumental effort, funded by Wellcome, the UK government, and various pharmaceutical companies,…
Read MoreGene editing, the science of altering the DNA of living organisms, has taken a massive step forward with the development of a groundbreaking tool known as the DANGER analysis. This exciting innovation promises to make gene editing safer and more accessible for researchers around the world. The DANGER analysis tool was created by a dedicated…
Read MoreMosquitoes and other insects are tiny, but they can carry some big problems, like diseases such as dengue and Zika virus. But what if we could make these insects less harmful to us? Scientists have been working on a clever plan involving special bacteria called Wolbachia, and their research, conducted at the University of California,…
Read MoreIn the ever-evolving struggle against microscopic adversaries, a fresh investigation from Australia offers a ray of hope. Researchers, spearheaded by Distinguished Professor Steven Djordjevic from the Australian Institute for Microbiology and Infection at the University of Technology Sydney, in collaboration with counterparts from the University of Melbourne and the University of South Australia, have recently…
Read More